Industry Sponsored Session | A Treatment Option for Patients with Certain Types of Advanced Endometrial Carcinoma Presented by Eisai

Please join us for a virtual N.E.X.T. Day Session, “A Treatment Option for Patients with Certain Types of Advanced Endometrial Carcinoma,” presented on behalf of Eisai Inc. Speaker Kimberly Halla, MSN, FNP-C will present the efficacy and safety results from the Phase 3 Study, as well as label recommendations for monitoring and managing adverse reactions. This session will educate oncology nurses on:

• Efficacy and safety results
• Recommended dosage and administration with this treatment option for patients with certain types of advanced endometrial carcinoma
• The most common ARs, most common grade 3-4 ARs, and most common serious ARs